Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT06176690
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-negative, Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type, +12 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
- Locations
-
- City of Hope Cancer Center (Data collection only) Duarte, California, United States
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
- University of California San Francisco (Data collection only) San Francisco, California, United States
- Stanford University Medical Center (Data collection only) Stanford, California, United States
Not Yet Recruiting
Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)
NCT07729397
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Diffuse Large B-Cell Lymphoma (DLBCL), +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
NCT02561273
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT01035463
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-negative, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
NCT02978625
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States
Active, Not Recruiting
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
NCT03113500
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, +26 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States